Liver Cirrhosis Recruiting Phase 2 Trials for Ambrisentan (DB06403)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03827200A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver CirrhosisTreatment